SERUM IMMUNOREACTIVE INTERLEUKIN-6 AND C-REACTIVE PROTEIN-LEVELS IN PATIENTS WITH MULTIPLE-MYELOMA AT DIAGNOSIS

Citation
A. Tienhaara et al., SERUM IMMUNOREACTIVE INTERLEUKIN-6 AND C-REACTIVE PROTEIN-LEVELS IN PATIENTS WITH MULTIPLE-MYELOMA AT DIAGNOSIS, British Journal of Haematology, 86(2), 1994, pp. 391-393
Citations number
12
Categorie Soggetti
Hematology
ISSN journal
00071048
Volume
86
Issue
2
Year of publication
1994
Pages
391 - 393
Database
ISI
SICI code
0007-1048(1994)86:2<391:SIIACP>2.0.ZU;2-P
Abstract
Serum bioactive but not immunoreactive interleukin-6 (IL-6), and serum C-reactive protein (CRP), have been reported to be of prognostic sign ificance in multiple myeloma (MM). We measured serum immunoreactive IL -6 by a sensitive enzyme-linked immunosorbent assay in 30 MM patients at diagnosis. In 30% of the patients serum immunoreactive IL-6 exceede d the upper reference limit. The concentrations of CRP and IL-6 showed a linear association. Logarithmically transformed IL-6, CRP and Pz-mi croglobulin were significant variables by univariate survival analysis ; by multivariate analysis CRP was a slightly stronger prognostic fact or than IL-6 and the only one of independent prognostic significance.